Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Biomarkers Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Framework
3.3.1 Reimbursement Framework
3.3.2 Standards & Compliances
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.5 Market Dynamics
3.5.1 Market Drivers Analysis
3.5.1.1 Increasing funding for biomarkers
3.5.1.2 Increasing prevalence of chronic diseases
3.5.1.3 Technological advancements
3.5.2 Market Restraint Analysis
3.5.2.1 Lack of reimbursement policies for biomarkers treatment
3.6 Biomarkers: Market Analysis Tools
3.6.1 Industry Analysis: Porter’s
3.6.2 Pestle Analysis
3.6.3 Major Deals And Strategic Alliances
3.6.3.1 New Product Launch
3.6.3.2 Acquisition
3.6.3.3 Partnerships
3.6.3.4 Marketing & Promotions
Chapter 4 Biomarkers Market: Segment Analysis, By Type, 2017 - 2028 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2020 & 2028
4.3 Segment Dashboard
4.4 Global Biomarkers Market, by Type, 2017 to 2028
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.5.1 Safety
4.5.1.1 Safety biomarkers market, 2017 - 2028 (USD Million)
4.5.2 Efficacy
4.5.2.1 Efficacy biomarkers market, 2017 - 2028 (USD Million)
4.5.3 Validation
4.5.3.1 Validation biomarkers market, 2017 - 2028 (USD Million)
Chapter 5 Biomarkers Market: Segment Analysis, By Application, 2017 - 2028 (USD Million)
5.1 Definition and Scope
5.2 Application Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Biomarkers Market, by Application, 2017 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
5.5.1 Diagnostics
5.5.1.1 Diagnostics market, 2017 - 2028 (USD Million)
5.5.2 Drug Discovery And Development
5.5.2.1 Drug discovery and development market, 2017 - 2028 (USD Million)
5.5.2.2 Preclinical trials
5.5.2.2.1 Introduction
5.5.2.2.2 Application
5.5.2.2.3 Regulations
5.5.2.2.4 Therapeutic gap in preclinical and clinical trial
5.5.2.2.5 Regional overview
5.5.2.2.6 Preclinical trials market, 2017- 2028 (USD Million)
5.5.2.3 Clinical trials
5.5.2.3.1 Clinical trials market, 2017- 2028 (USD Million)
5.5.3 Personalized Medicine
5.5.3.1 Personalized medicine market, 2017 - 2028 (USD Million)
5.5.4 Others
5.5.4.1 Others market, 2017 - 2028 (USD Million)
Chapter 6 Biomarkers Market: Segment Analysis, By Diseases, 2017 - 2028 (USD Million)
6.1 Definition and Scope
6.2 Diseases Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Biomarkers Market, by Diseases, 2020 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.5.1 Cancer
6.5.1.1 Cancer biomarkers market, 2017 - 2028 (USD Million)
6.5.2 Cardiovascular Diseases
6.5.2.1 Cardiovascular disease biomarkers market, 2017 - 2028 (USD Million)
6.5.3 Neurological Diseases
6.5.3.1 Neurological disease biomarkers market, 2017 - 2028 (USD Million)
6.5.4 Immunological Diseases
6.5.4.1 Immunological disease biomarkers market, 2017 - 2028 (USD Million)
6.5.5 Others
6.5.5.1 Other biomarkers market, 2017 - 2028 (USD Million)
Chapter 7 Biomarkers Market: Segment Analysis, By Region, 2017 - 2028 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2020 & 2028
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Regional Market Share and Leading Players, 2020
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East And Africa
7.6 Swot Analysis
7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East And Africa
7.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2020 to 2028
7.7.1 North America
7.7.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
7.7.1.2 U.S.
7.7.1.2.1 U.S. biomarkers market, 2017 - 2028 (USD Million)
7.7.1.3 Canada
7.7.1.3.1 Canada biomarkers market, 2017 - 2028 (USD Million)
7.7.2 Europe
7.7.2.1 Europe biomarkers market, 2017 - 2028 (USD Million)
7.7.2.2 U.K.
7.7.2.2.1 U.K. biomarkers market, 2017 - 2028 (USD Million)
7.7.2.3 Germany
7.7.2.3.1 Germany biomarkers market, 2017 - 2028 (USD Million)
7.7.2.4 Spain
7.7.2.4.1 Spain biomarkers market, 2017 - 2028 (USD Million)
7.7.2.5 France
7.7.2.5.1 France biomarkers market, 2017 - 2028 (USD Million)
7.7.2.6 Italy
7.7.2.6.1 Italy biomarkers market, 2017 - 2028 (USD Million)
7.7.3 Asia Pacific
7.7.3.1 Asia Pacific biomarkers market, 2017 - 2028 (USD Million)
7.7.3.2 Japan
7.7.3.2.1 Japan biomarkers market, 2017 - 2028 (USD Million)
7.7.3.3 China
7.7.3.3.1 China biomarkers market, 2017 - 2028 (USD Million)
7.7.3.4 India
7.7.3.4.1 India biomarkers market, 2017 - 2028 (USD Million)
7.7.3.5 South Korea
7.7.3.5.1 South Korea biomarkers market, 2017 - 2028 (USD Million)
7.7.3.6 Australia
7.7.3.6.1 Australia biomarkers market, 2017 - 2028 (USD Million)
7.7.4 Latin America
7.7.4.1 Latin America biomarkers market, 2017 - 2028 (USD Million)
7.7.4.2 Brazil
7.7.4.2.1 Brazil biomarkers market, 2017 - 2028 (USD Million)
7.7.4.3 Mexico
7.7.4.3.1 Mexico biomarkers market, 2017 - 2028 (USD Million)
7.7.4.4 Argentina
7.7.4.4.1 Argentina biomarkers market, 2017 - 2028 (USD Million)
7.7.5 MEA
7.7.5.1 MEA biomarkers market, 2017 - 2028 (USD Million)
7.7.5.2 South Africa
7.7.5.2.1 South Africa biomarkers market, 2017 - 2028 (USD Million)
7.7.5.3 Saudi Arabia
7.7.5.3.1 Saudi Arabia biomarkers market, 2017 - 2028 (USD Million)
7.7.5.4 UAE
7.7.5.4.1 UAE biomarkers market, 2017 - 2028 (USD Million)
Chapter 8 Biomarkers Market: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Ansoff Matrix
8.1.2 Heat Map Analysis
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2020
8.4 Public Companies
8.4.1 Company Market Position Analysis
8.4.2 Company Market Position Analysis
8.4.3 Company Market Share, By Region
8.4.4 Competitive Dashboard Analysis
8.4.4.1 Market Differentiators
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Company Profiles
8.6.1 F. HOFFMANN-LA ROCHE LTD.
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic initiatives
8.6.2 ABBOTT LABORATORIES
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic initiatives
8.6.3 EPIGENOMICS AG
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic initiatives
8.6.4 GENERAL ELECTRIC
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic initiatives
8.6.5 JOHNSON & JOHNSON SERVICES, INC.
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic initiatives
8.6.6 THERMO FISHER SCIENTIFIC, INC.
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic initiatives
8.6.7 BIO-RAD LABORATORIES, INC.
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 SIEMENS HEALTHINEERS AG
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 QIAGEN
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives



List of Figures

List of Figures

Fig. 1 Biomarkers market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2020)
Fig. 10 Segment Outlook (Disease Type, 2020)
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 PESTLE analysis
Fig. 18 Strategy mapping
Fig. 19 Biomarkers market: Type movement analysis
Fig. 20 Type segment dashboard
Fig. 21 Biomarkers market type outlook: Key takeaways
Fig. 22 Safety biomarkers market, 2017 - 2028 (USD million)
Fig. 23 Efficacy biomarkers market, 2017 - 2028 (USD million)
Fig. 24 Validation biomarkers market, 2017 - 2028 (USD million)
Fig. 25 Biomarkers market: Application movement analysis
Fig. 26 Application segment dashboard
Fig. 27 Biomarkers application outlook: Key takeaways
Fig. 28 Diagnostics market, 2017 - 2028 (USD million)
Fig. 29 Drug discovery & development market, 2017 - 2028 (USD million)
Fig. 30 Preclinical trials market, 2017 - 2028 (USD million)
Fig. 31 Clinical trials market, 2017 - 2028 (USD million)
Fig. 32 Personalized market, 2017 - 2028 (USD million)
Fig. 33 Others market, 2017 - 2028 (USD million)
Fig. 34 Biomarkers market: Diseases movement analysis
Fig. 35 Diseases segment dashboard
Fig. 36 Biomarkers market sales channel outlook: Key takeaways
Fig. 37 Cancer biomarkers market, 2017 - 2028 (USD million)
Fig. 38 Cardiovascular disease biomarkers market, 2017 - 2028 (USD million)
Fig. 39 Neurological disease biomarkers market, 2017 - 2028 (USD million)
Fig. 40 Immunological disease biomarkers market, 2017 - 2028 (USD million)
Fig. 41 Other biomarkers market, 2017 - 2028 (USD million)
Fig. 42 Regional outlook, 2020 & 2028
Fig. 43 Regional market dashboard
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America market share and key players (2020)
Fig. 46 Europe market share and key players (2020)
Fig. 47 Asia Pacific market share and key players (2020)
Fig. 48 Latin America market share and key players (2020)
Fig. 49 Middle East and Africa market share and key players (2020)
Fig. 50 North America, SWOT
Fig. 51 Europe, SWOT
Fig. 52 Asia Pacific, SWOT
Fig. 53 Latin America, SWOT
Fig. 54 Middle East and Africa, SWOT
Fig. 55 North America
Fig. 56 North America biomarkers market, 2017 - 2028 (USD Million)
Fig. 57 U.S.
Fig. 58 U.S. biomarkers market, 2017 - 2028 (USD Million)
Fig. 59 Canada
Fig. 60 Canada biomarkers market, 2017 - 2028 (USD Million)
Fig. 61 Europe
Fig. 62 Europe biomarkers market, 2017 - 2028 (USD Million)
Fig. 63 U.K.
Fig. 64 U.K. biomarkers market, 2017 - 2028 (USD Million)
Fig. 65 Germany
Fig. 66 Germany biomarkers market, 2017 - 2028 (USD Million)
Fig. 67 Spain
Fig. 68 Spain biomarkers market, 2017 - 2028 (USD Million)
Fig. 69 France
Fig. 70 France biomarkers market, 2017 - 2028 (USD Million)
Fig. 71 Italy
Fig. 72 Italy biomarkers market, 2017 - 2028 (USD Million)
Fig. 73 Asia Pacific
Fig. 74 Asia Pacific biomarkers market, 2017 - 2028 (USD Million)
Fig. 75 Japan
Fig. 76 Japan biomarkers market, 2017 - 2028 (USD Million)
Fig. 77 China
Fig. 78 China biomarkers market, 2017 - 2028 (USD Million)
Fig. 79 India
Fig. 80 India biomarkers market, 2017 - 2028 (USD Million)
Fig. 81 South Korea
Fig. 82 South Korea biomarkers market, 2017 - 2028 (USD Million)
Fig. 83 Australia
Fig. 84 Australia biomarkers market, 2017 - 2028 (USD Million)
Fig. 85 Latin America
Fig. 86 Latin America biomarkers market, 2017 - 2028 (USD Million)
Fig. 87 Brazil
Fig. 88 Brazil biomarkers market, 2017 - 2028 (USD Million)
Fig. 89 Mexico
Fig. 90 Mexico biomarkers market, 2017 - 2028 (USD Million)
Fig. 91 Argentina
Fig. 92 Argentina biomarkers market, 2017 - 2028 (USD Million)
Fig. 93 Middle East and Africa
Fig. 94 MEA biomarkers market, 2017 - 2028 (USD Million)
Fig. 95 South Africa
Fig. 96 South Africa biomarkers market, 2017 - 2028 (USD Million)
Fig. 97 Saudi Arabia
Fig. 98 Saudi Arabia biomarkers market, 2017 - 2028 (USD Million)
Fig. 99 UAE
Fig. 100 UAE biomarkers market, 2017 - 2028 (USD Million)
Fig. 101 Ansoff Matrix
Fig. 102 Heat map analysis
Fig. 103 Company market share analysis
Fig. 104 Company market position analysis (2020)
Fig. 105 Company market position analysis (2020)
Fig. 106 Company market share, by region
Fig. 107 Market differentiators

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Estimated new cancer case statistics 2012 & 2018
Table 4 Role of preclinical biomarkers and their impact on business
Table 5 Key preclinical biomarker applications in animals
Table 6 Regional overview of preclinical biomarkers
Table 7 Global Biomarkers, By Region, 2017 - 2028 (USD Million)
Table 8 Global Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 9 Global Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 10 Global Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 11 North America Biomarkers, By Country, 2017 - 2028 (USD Million)
Table 12 North America Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 13 North America Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 14 North America Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 15 U.S. Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 16 U.S. Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 17 U.S. Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 18 Canada Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 19 Canada Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 20 Canada Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 21 Europe Biomarkers, By Country, 2017 - 2028 (USD Million)
Table 22 Europe Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 23 Europe Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 24 Europe Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 25 Germany Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 26 Germany Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 27 Germany Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 28 U.K. Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 29 U.K. Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 30 U.K. Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 31 France Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 32 France Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 33 France Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 34 Italy Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 35 Italy Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 36 Italy Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 37 Spain Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 38 Spain Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 39 Spain Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 40 Asia Pacific Biomarkers, By Country, 2017 - 2028 (USD Million)
Table 41 Asia Pacific Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 42 Asia Pacific Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 43 Asia Pacific Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 44 Japan Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 45 Japan Biomarkers, By Application 2017 - 2028 (USD Million)
Table 46 Japan Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 47 China Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 48 China Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 49 China Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 50 India Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 51 India Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 52 India Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 53 Australia Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 54 Australia PCR Market, By Application, 2017 - 2028 (USD Million)
Table 55 Australia Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 56 South Korea Biomarkers, By Type 2017 - 2028 (USD Million)
Table 57 South Korea Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 58 South Korea Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 59 Latin America Biomarkers, By Country, 2017 - 2028 (USD Million)
Table 60 Latin America Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 61 Latin America Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 62 Latin America Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 63 Brazil Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 64 Brazil Biomarkers, By Application 2017 - 2028 (USD Million)
Table 65 Brazil Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 66 Mexico Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 67 Mexico Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 68 Mexico Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 69 Argentina Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 70 Argentina Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 71 Argentina Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 72 Middle East & Africa Biomarkers, By Country, 2017 - 2028 (USD Million)
Table 73 Middle East & Africa Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 74 Middle East & Africa Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 75 Middle East & Africa Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 76 Saudi Arabia Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 77 Saudi Arabia Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 78 Saudi Arabia Biomarkers, By Disease , 2017 - 2028 (USD Million)
Table 79 South Africa Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 80 South Africa Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 81 South Africa Biomarkers, By Disease, 2017 - 2028 (USD Million)
Table 82 UAE Biomarkers, By Type, 2017 - 2028 (USD Million)
Table 83 UAE Biomarkers, By Application, 2017 - 2028 (USD Million)
Table 84 UAE Biomarkers, By Disease, 2017 - 2028 (USD Million)